Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
18th June 1998 - 09th July 1998
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Guideline study with acceptable restrictions: no positive control

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1998
Report date:
1998

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Version / remarks:
Guinea Pig Maximization Test
Deviations:
yes
Remarks:
, no positive control
GLP compliance:
yes
Type of study:
guinea pig maximisation test

Test material

Constituent 1
Chemical structure
Reference substance name:
Dimethylammonium 2,4-dichlorophenoxyacetate
EC Number:
217-915-8
EC Name:
Dimethylammonium 2,4-dichlorophenoxyacetate
Cas Number:
2008-39-1
Molecular formula:
C8H6Cl2O3.C2H7N
IUPAC Name:
dimethylammonium 2,4-dichlorophenoxyacetate
Details on test material:
- Name of test material (as cited in study report): Aminopielik 600 SL
- Physical state: light brown solution with a characteristic smell
- Analytical purity: 606 g/L active substance expressed as 2,4-D acid
- Impurities (identity and concentrations):
Chlorphenols, expressed as 2,4-dichlorphenol = 0.16%
- Purity test date: 19 May 1998
- Other:
pH = 7.6

In vivo test system

Test animals

Species:
guinea pig
Strain:
not specified
Sex:
male/female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Institute of occupational medicine, Lodz, Poland
- Age at study initiation: 3 months (mean)
- Weight at study initiation: males = 658 g (mean), females = 613 g (mean)
- Housing: individually in plast-metalic cages (35 x 30 x 20 cm3)
- Diet: granulated standard food "LSK" ad libitum
- Water: with ascorbic acid ad libitum
- Acclimation period: 7 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 ± 3
- Humidity (%): 40 - 80
- Photoperiod (hrs dark / hrs light): 12/12

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal and epicutaneous
Vehicle:
water
Concentration / amount:
induction: intradermal injection 1% , epicutaneous application 50%
challenge: epicutaneous application 40%
Challengeopen allclose all
Route:
epicutaneous, occlusive
Vehicle:
water
Concentration / amount:
induction: intradermal injection 1% , epicutaneous application 50%
challenge: epicutaneous application 40%
No. of animals per dose:
8 male and 4 female animals in the treated group,
5 males and 1 female in the control group
Details on study design:
RANGE FINDING TESTS: Yes (June 1998)
- 4 intradermal injections (1, 2.5, 3, and 5% water solutions of the test substance) of 0.1 mL were administered to the shoulder region of one animal. The skin reaction was observed after 24, 48 and 72 h. A concentration of 1% was chosen for the intradermal injection (induction) as it caused mild-to-moderate skin irritation.
- For the induction and challenge by topical application the concentration of the test substance was established on 4 animals. 30, 40 and 50% water solutions of the test substance were examined. For the induction by topical application the 50% solution was chosen, which caused a mild skin irritation to one animal. For the challenge the 40% solution was chosen, as it was the highest concentration that induced no skin irritation.

MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2
- Exposure period: topical induction - 48 h
- Test groups: 1
- Control group: 1 (vehicle control)
- Site: A series of three pairs of intradermal injections of 0.1 mL were given in the shoulder region
- Frequency of applications: Days 0 (injection) and 7 (topical)
- Duration: 21 days
- Concentrations: intradermal induction: 1%, topical induction: 50%
- Other: 24 before topical induction treatment, 0.5 ml of 10% sodium lauryl sulfate in vaseline was applied to the test area of the animals in order to create a local irritation

B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 14 days after last induction application
- Exposure period: 24 hours
- Test groups: 1
- Control group: 1 (vehicle control)
- Site: left flank
- Concentration: 40%
- Evaluation (hr after challenge): 24, 48 and 72 hours after end of exposure
Positive control substance(s):
no

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
40% solution of the test substance
No. with + reactions:
1
Total no. in group:
12
Clinical observations:
discret to moderate erythema
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 40% solution of the test substance. No with. + reactions: 1.0. Total no. in groups: 12.0. Clinical observations: discret to moderate erythema.
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
40% solution of the test substance
No. with + reactions:
5
Total no. in group:
12
Clinical observations:
discret to moderate erythema
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 40% solution of the test substance. No with. + reactions: 5.0. Total no. in groups: 12.0. Clinical observations: discret to moderate erythema.
Reading:
other: 3rd reading
Hours after challenge:
72
Group:
test chemical
Dose level:
40% solution of the test substance
No. with + reactions:
5
Total no. in group:
12
Clinical observations:
discrete erythema
Remarks on result:
other: Reading: other: 3rd reading. . Hours after challenge: 72.0. Group: test group. Dose level: 40% solution of the test substance. No with. + reactions: 5.0. Total no. in groups: 12.0. Clinical observations: discrete erythema.
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
water
No. with + reactions:
0
Total no. in group:
6
Clinical observations:
no effects observed
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: water. No with. + reactions: 0.0. Total no. in groups: 6.0. Clinical observations: no effects observed.
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
water
No. with + reactions:
0
Total no. in group:
6
Clinical observations:
no effects observed
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: water. No with. + reactions: 0.0. Total no. in groups: 6.0. Clinical observations: no effects observed.
Reading:
other: 3rd reading
Hours after challenge:
72
Group:
negative control
Dose level:
water
No. with + reactions:
0
Total no. in group:
6
Clinical observations:
no effects observed
Remarks on result:
other: Reading: other: 3rd reading. . Hours after challenge: 72.0. Group: negative control. Dose level: water. No with. + reactions: 0.0. Total no. in groups: 6.0. Clinical observations: no effects observed.

Any other information on results incl. tables

Table 1a: Evaluation of challenge patch test reaction – control

Parameter

Sex

Animal No.

Evaluation after x hours

Left flank

40% concentration

Right flank

water

24

48

72

24

48

72

Erythema/

Swelling

Male

1

2

3

4

5

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

female

6

0

0

0

0

0

0

Table 1b: Evaluation of challenge patch test reaction – treated animals

Parameter

Sex

Animal No.

Evaluation after x hours

Left flank

40% concentration

Right flank

water

24

48

72

24

48

72

Erythema/

Swelling

Male

1

2

3

4

5

6

7

8

0

0

0

0

0

0

0

0

1

0

1

1

0

0

0

2

1

0

1

1

0

0

0

1

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

female

9

10

11

12

0

0

0

1

0

0

0

1

0

0

0

1

0

0

0

0

0

0

0

0

0

0

0

0

Table 2: Body weight (g)

Group

Sex

Animal No.

Day of the study

Difference day 1 till day 25

0

25

treated

male

1

2

3

4

5

6

7

8

677

690

667

708

575

551

624

636

696

719

751

741

594

582

642

688

19

29

84

33

19

31

18

52

female

9

10

11

12

546

530

518

534

584

591

534

574

38

61

16

40

control

male

1

2

3

4

5

666

663

781

645

620

715

695

781

659

670

49

32

0

14

50

female

6

695

761

66

Applicant's summary and conclusion

Interpretation of results:
sensitising
Remarks:
Migrated information